TNFSF10 and neoplasm: Similarly, an oncolytic HSV-TRAIL suppressed tumor progression and cured 40% of treated mice when used with a TGF-β inhibitor, which plays a crucial role in preserving the stemness of glioblastoma stem cells [162].